Form 4: Abeona Therapeutics Director Acquires Shares
SEC Form 4 Filing
Director Michael Amoroso acquired 23,611 shares of Abeona Therapeutics on July 8, 2024.
Summary
- On July 8, 2024, Michael Amoroso, a director of Abeona Therapeutics Inc., acquired 23,611 shares of common stock.
- The shares were acquired at a price of $0.00.
- Following the transaction, Amoroso directly owns 132,568 shares of Abeona Therapeutics Inc.
- The restricted stock will vest on July 8, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative.
Positives
- A director increasing their holdings could be seen as a positive signal about their confidence in the company's future.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of transaction: Michael Amoroso acquired 23,611 shares of Abeona Therapeutics Inc. |
| 07/08/2025 | Vesting date for the restricted stock. |
| 07/09/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.